|
WDR12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.572000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.335500E-03 |
| Normal-vs-Stage2 |
1.124110E-02 |
| Normal-vs-Stage3 |
4.458900E-03 |
| Normal-vs-Stage4 |
2.542400E-02 |
| Stage1-vs-Stage2 |
5.095600E-01 |
| Stage1-vs-Stage3 |
6.896800E-01 |
| Stage1-vs-Stage4 |
9.270600E-01 |
| Stage2-vs-Stage3 |
7.549800E-01 |
| Stage2-vs-Stage4 |
5.442000E-01 |
| Stage3-vs-Stage4 |
7.215400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.638830E-03 |
| Normal-vs-AfricanAmerican |
2.176800E-01 |
| Normal-vs-Asian |
3.086000E-02 |
| Caucasian-vs-AfricanAmerican |
4.984800E-01 |
| Caucasian-vs-Asian |
9.774000E-01 |
| AfricanAmerican-vs-Asian |
5.622400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.037700E-04 |
| Normal-vs-Female |
4.402100E-03 |
| Male-vs-Female |
4.928200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.794350E-02 |
| Normal-vs-Age(41-60Yrs) |
7.82220000000722E-05 |
| Normal-vs-Age(61-80Yrs) |
9.989500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.339420E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.144400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.501400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.147600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.316000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.512400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.935000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.012820E-01 |
| Classical-VS-Follicular |
7.477900E-02 |
| Classical-VS-Other |
2.467800E-01 |
| Classical-VS-Normal |
1.617950E-02 |
| Tall-VS-Follicular |
2.447800E-02 |
| Tall-VS-Other |
1.013010E-01 |
| Tall-VS-Normal |
8.488800E-01 |
| Follicular-VS-Other |
7.129200E-01 |
| Follicular-VS-Normal |
5.775300E-04 |
| Other-VS-Normal |
1.940190E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.8436000000015E-05 |
| Normal-vs-N1 |
8.295800E-03 |
| N0-vs-N1 |
8.071200E-01 |
|
|
